For when a bandaid isn’t enough. Via The Daily:
The maker of OxyContin is seeking Food and Drug Administration approval to label the controversial painkiller for use by children as young as 6 in a move that could serve to extend the company’s expiring patent on the lucrative drug.
Purdue Pharma has paid dozens of clinical sites around the country to document what happens when OxyContin, an addictive pharmaceutical widely abused by recreational users, is given to children. The family-owned pharmaceutical company earned an estimated $2.8 billion in revenue last year from sales of the powerful opioid, part of the same drug family as morphine and heroin.
Latest posts by JacobSloan (see all)
- For Sale: Poveglia, The Haunted Italian Island With A Chilling History - Apr 20, 2014
- Lab Is Missing 2,000 Vials Of The Deadly SARS Virus - Apr 19, 2014
- Essential Vitamin B3 May Have Arrived From Space On Meteorites - Apr 18, 2014